Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) were up 3.7% during trading on Wednesday . The company traded as high as $32.47 and last traded at $31.46, with a volume of 1,064,322 shares traded. The stock had previously closed at $30.35.

ZLTQ has been the subject of several research reports. Goldman Sachs Group Inc. lifted their price objective on shares of Zeltiq Aesthetics from $35.00 to $37.00 in a research note on Friday, April 8th. Brean Capital restated a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, April 28th. TheStreet upgraded shares of Zeltiq Aesthetics from a “hold” rating to a “buy” rating in a research note on Wednesday, April 20th. Stifel Nicolaus restated a “buy” rating and set a $38.00 price objective on shares of Zeltiq Aesthetics in a research note on Friday, May 13th. Finally, Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, June 30th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Zeltiq Aesthetics has an average rating of “Buy” and a consensus price target of $36.25.

The company has a 50 day moving average of $28.36 and a 200 day moving average of $26.22. The company has a market capitalization of $1.27 billion and a P/E ratio of 38.81.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last announced its quarterly earnings results on Tuesday, May 10th. The company reported ($0.25) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.25). During the same quarter in the prior year, the company earned ($0.06) earnings per share. The company earned $64.50 million during the quarter, compared to analysts’ expectations of $61.80 million. The business’s revenue for the quarter was up 25.0% on a year-over-year basis. On average, equities research analysts expect that Zeltiq Aesthetics Inc. will post $0.01 earnings per share for the current year.

In other Zeltiq Aesthetics news, insider Keith J. Sullivan sold 8,000 shares of the stock in a transaction that occurred on Monday, July 11th. The shares were sold at an average price of $30.02, for a total value of $240,160.00. Following the transaction, the insider now directly owns 77,922 shares in the company, valued at $2,339,218.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Bradley Hauser sold 3,000 shares of the stock in a transaction that occurred on Monday, July 11th. The shares were sold at an average price of $30.02, for a total transaction of $90,060.00. Following the completion of the transaction, the vice president now owns 47,184 shares in the company, valued at $1,416,463.68. The disclosure for this sale can be found here.

Other institutional investors have made changes to their positions in the company. Russell Frank Co raised its position in shares of Zeltiq Aesthetics by 98.0% in the fourth quarter. Russell Frank Co now owns 211,197 shares of the company’s stock worth $6,044,000 after buying an additional 104,550 shares during the period. EAM Investors LLC raised its position in shares of Zeltiq Aesthetics by 3.5% in the fourth quarter. EAM Investors LLC now owns 78,374 shares of the company’s stock worth $2,236,000 after buying an additional 2,670 shares during the period. Trexquant Investment LP acquired a new position in shares of Zeltiq Aesthetics during the fourth quarter worth about $1,640,000. California State Teachers Retirement System raised its position in shares of Zeltiq Aesthetics by 1.7% in the fourth quarter. California State Teachers Retirement System now owns 59,726 shares of the company’s stock worth $1,704,000 after buying an additional 984 shares during the period. Finally, CAM Group Holding A S raised its position in shares of Zeltiq Aesthetics by 100.0% in the fourth quarter. CAM Group Holding A S now owns 150,000 shares of the company’s stock worth $4,280,000 after buying an additional 75,000 shares during the period.

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.